Pharma & Biotech

ECTRIMS 2025: OCREVUS confirms benefit in advanced PPMS and paediatric MS as fenebrutinib shows durable two-year results

(IN BRIEF) Roche presented new data at ECTRIMS 2025 confirming that OCREVUS provides sustained protection against disability progression and maintains…

1 week ago

Sanofi Ventures surpasses $1.4 billion with new capital to accelerate early-stage medical innovation

(IN BRIEF) Sanofi has boosted its venture capital arm, Sanofi Ventures, with a new $625 million multi-year commitment, raising the…

1 week ago

Bayer strengthens natural health research with advanced phytomedicines lab in Germany

(IN BRIEF) Bayer has officially opened a modern laboratory in Darmstadt, Germany, designed to accelerate research and development in phytomedicines…

2 weeks ago

GSK announces $30 billion U.S. investment to advance biopharma R&D and manufacturing with AI-powered facilities

(IN BRIEF) GSK announced a $30 billion investment plan across the United States over the next five years, expanding its…

2 weeks ago

Boehringer Ingelheim secures NMPA approval for HERNEXEOS® in HER2-mutant NSCLC with 71% response rate in Beamion-LUNG 1

(IN BRIEF) Boehringer Ingelheim’s HERNEXEOS® (zongertinib tablets) has received accelerated approval in China for patients with advanced NSCLC carrying HER2…

1 month ago